AmgenvsQ32 Bio

AMGN and QTTB stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$443.89

Value $239B

-3.07%
AMGN's page

Amgen (AMGN) has a market value of $239B and Q32 Bio (QTTB) $255M. Over the last year, with dividends, AMGN moved +33.5% and QTTB +272.5%. The P/E is 25.5 for AMGN and 7.9 for QTTB. Dividend yield: AMGN 2.24%, QTTB none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$239B

    QTTB$255M

    AMGN is 937 times QTTB

  • Revenue, 12 months

    AMGN$38.9B

    QTTB$54M

    AMGN is 724 times QTTB

  • Net income, 12 months

    AMGN$9.4B

    QTTB$32M

    AMGN is 291 times QTTB

  • Operating margin

    AMGN32.4%

    QTTB31.5%

    0.9 points apart

  • ROIC

    AMGN16.2%

    QTTB31.8%

    15.6 points apart

  • P/E

    AMGN25.5

    QTTB7.9

    AMGN is 3.2 times QTTB

  • Dividend yield

    AMGN2.2%

    QTTB0.0%

    2.2 points apart

  • 5-year return

    AMGN+149.9%

    QTTB-91.3%

    241.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+149.9%

QTTB-91.3%

010020020222023202420252026
Returns by period
PeriodAMGNWith dividendsQTTBWith dividends
1 year since November 17, 2025+33.5%Price +29.9%+272.5%Price +272.5%
3 years since November 17, 2023+81.6%+22.0% a yearPrice +67.3%-15.4%-5.4% a yearPrice -15.4%
5 years since November 17, 2021+149.9%+20.1% a yearPrice +115.7%-91.3%-38.7% a yearPrice -91.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenQTTBQ32 Bio

Valuation

AMGNQTTB
Valuation
Price$443.89$8.53
Market value$239B$255M
Enterprise value (EV)$280B–
P/E25.57.9
P/E, 5-year median23.0–
P/B16.70.9
EV/EBIT22.2–
Free cash flow yield4.0%–

Results and growth

AMGNQTTB
Results and growth
Revenue, 12 months$38.9B$54M
Net income, 12 months$9.4B$32M
Free cash flow, 12 months$9.6B-$20M
Earnings per share, 12 months$17.25$1.08
Revenue growth, year on year10.0%–
Revenue growth a year, past+7.6%over 5 years+81.9%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNQTTB
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%31.5%
Net margin24.1%55.5%
ROIC16.2%31.8%
ROE87.8%34.8%

Balance sheet

AMGNQTTB
Balance sheet
Cash$13.2B$290M
Total debt$54.0B$8.6M
Net debt / EBITDA2.3-16.6
Interest cover4.8×–

Dividends and buybacks

AMGNQTTB
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or QTTB

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Q32 Bio?

By market value, Amgen ($239B) is about 937.5 times Q32 Bio ($255M), at today's prices.

How did AMGN and QTTB stock do over the last 5 years?

Since November 17, 2021, AMGN's price moved +115.7% and QTTB's -91.3%. With dividends: AMGN +149.9% (+20.1% a year), QTTB -91.3% (-38.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or QTTB?

The dividend yield at today's price is 2.24% for Amgen and none for Q32 Bio. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and QTTB?

At today's price, the P/E is 25.5 for AMGN and 7.9 for QTTB. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or Q32 Bio?

Over the last twelve months, the net margin was 24.1% for Amgen and 55.5% for Q32 Bio, and the operating margin 32.4% and 31.5%. Revenue was $38.9B and $54M.

Which is the better investment, Amgen or Q32 Bio?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.